Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteases in brain tumour progression.

N Levicar1, R K Nuttall, T T Lah

  • 1Department of Genetic Toxicology and Cancer biology, National Institute of Biology, Ljubljana, Slovenia.

Acta Neurochirurgica
|September 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and normal astrocytes.

Phytotherapy research : PTR·2012
Same author

ERK5 signalling in prostate cancer promotes an invasive phenotype.

British journal of cancer·2011
Same author

[Prognostic implications of biologic markers in intracranial meningiomas: 120 cases].

Neuro-Chirurgie·2008
Same author

Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human.

Cancer gene therapy·2008
Same author

Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease.

Cell proliferation·2008
Same author

Stem cells as a treatment for chronic liver disease and diabetes.

Handbook of experimental pharmacology·2007

Brain tumor invasion involves peptidases like plasminogen activators, matrix metalloproteinases, and cathepsins. Targeting these enzymes may inhibit tumor spread and improve outcomes.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Local invasion is a hallmark of brain tumor progression, driven by increased cell motility and extracellular matrix degradation.
  • Specific peptidases, including plasminogen activators (PAs), matrix metalloproteinases (MMPs), and cathepsins (Cats), are implicated in this invasive process.

Purpose of the Study:

  • To review the roles of key peptidases in brain tumor invasion.
  • To highlight the expression patterns and functional significance of PAs, MMPs, and cathepsins in brain tumors.

Main Methods:

  • Review of existing literature on peptidase expression and function in brain tumors.
  • Analysis of data on the localization and correlation of specific peptidases with tumor grade and patient survival.

Related Experiment Videos

Main Results:

  • Elevated urokinase-type plasminogen activator (uPA) at invasive margins; controversial data for tissue-type PA (tPA).
  • Matrix metalloproteinases (MMPs), particularly MMP2 and MMP9, correlate with glioma progression; MT-MMPs activate MMP-2.
  • Cathepsin B is highly expressed in malignant gliomas and glioblastomas, predicting shorter survival and serving as a malignancy marker in meningiomas.

Conclusions:

  • Peptidases like PAs, MMPs, and cathepsins are crucial for brain tumor cell invasion and malignant behavior.
  • Targeting these peptidases offers a potential therapeutic strategy to control local tumor spread.